# HBOW

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hbow

- Industry: Biotechnology
- Headquarters: Shaoxing, China
- Latest round: Angel (Jan 13, 2022)
- Investors on record: 2

## About

Established in 2021 and based in Shaoxing, China, HBOW is a fluorescence-targeted original new drug developer of drugs for intraoperative imaging of solid tumors. The Company has filed a Pre-IND application for a new drug during 2023. In October 2023, the company closed a round of pre-series A funding.

The Company focuses on the development of fluorescent-targeted contrast agents for intraoperative imaging of solid tumors to assist physicians in tumor resection procedures. The specific product is an infrared hypoxia-targeted contrast agent, NC527-X, which can be used for intraoperative real-time lesion-specific coloration of various solid tumors.

## Funding rounds

- Angel, Jan 13, 2022 — Sherpa Healthcare Partners, NHH Ventures

## Investors

- Sherpa Healthcare Partners (https://capitalatlas.ai/funds/sherpa-healthcare-partners) — Angel
- NHH Ventures — Angel